<DOC>
	<DOCNO>NCT01885988</DOCNO>
	<brief_summary>The study take part The Men 's Health Center It involve men diagnosis erectile dysfunction also high blood pressure . High blood pressure affect line artery cause stiffness artery . The artery vein throughout body lining call endothelium give ability stretch . If line penile artery become impaired , decrease stretch artery decrease blood flow . Decreased blood flow penile artery cause problem obtain erection . The study medication Nebivolol control blood pressure relax smooth muscle around line artery , thereby improve stretch blood flow . The primary objective determine treatment nebivolol improve endothelial function erectile function men pre-hypertension stage 1 hypertension 70 men enrol study . Half subject receive active medication half receive placebo . All men receive educational informational handout blood pressure behavior modification improve blood pressure . The study last 3 month subject . The expected recruitment time one year , 2 year study completion goal . Subjects approximately 5 study visit . Subjects initial/final blood work , Rigiscan test ( take home penile erection test ) , two EndoPat test assess endothelium function , 3 SphygmoCor test assess central blood pressure , 2 sexual health questionnaire 2 visit . Vital sign monitor visit ass safety effectiveness study medication .</brief_summary>
	<brief_title>Nebivolol Effects Endothelial Function Erectile Function</brief_title>
	<detailed_description>Randomized double-blind placebo-controlled study 70 non-smoking pre-hypertensive men ( BP 120-139 / 80-89 ) newly diagnose stage 1 hypertension ( BP &gt; 140 &lt; 159/ 90-99 ) erectile dysfunction receive nebivolol ( 5-20mg ) placebo , along lifestyle modification , daily 3 month titrate BP 120/80 le .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Males 2565 Male Patients ED ( IIEF5 ) Score &gt; 13 &lt; 21 If subject use PDE5 's ( phosphodiesterase type 5 inhibitor ) , must two week washout PDE5 use , two week without PDE5 use ; 4 attempt sexual activity IIEF score &lt; 21 least 2 four effort Treatment na√Øve patient Prehypertension ( BP 120139/8089 ) Stage 1 hypertension ( BP &gt; 140 &lt; 159/ 9099 ) Patients stable , monogamous relationship Patients able comprehend satisfactorily comply protocol requirement Eugonadal Men : Total Testosterone 300 ng/dL1000 ng/dL great , well men eugonadal treatment . Nonsmoker Men concomitant Type 1 Type 2 Diabetes Mellitus Normal RigiScan Baseline Concomitant use ACE/ ARB ( angiotensin receptor blocker ) / Betablocking agents/CCB ( calcium channel blocker ) / alphablocker Concomitant use PDE5 'S Currently Smoking Meeting exclusion criterion beta blocker use state nebivolol package insert Patients medical condition , Investigator 's opinion , would expose increase risk significant adverse event interfere assessment safety efficacy course trial . Patients current malignancy , clinically significant hematological , endocrine , cardiovascular , renal , hepatic , gastrointestinal neurological disease . If history disease condition stable least past year judge investigator interfere patient 's participation study , patient may include . Patients unable speak , read , understand English judge investigator unable unlikely follow study protocol complete schedule visit .</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Erectile dysfunction</keyword>
</DOC>